Dermatofibrosarcoma protuberans(DFSP)is a rare cutaneous intermediate-grade soft tissue tumor characterized by COL1A1::PDGFB fusion in most cases.This fusion drives tumorigenesis and forms the basis for imatinib treat...Dermatofibrosarcoma protuberans(DFSP)is a rare cutaneous intermediate-grade soft tissue tumor characterized by COL1A1::PDGFB fusion in most cases.This fusion drives tumorigenesis and forms the basis for imatinib treatment,which acts by blocking platelet-derived growth factor receptor-beta kinase activity.Apart from this canonical fusion,there is an expanding spectrum of rare fusions,including COL6A3::PDGFD,EMILIN::PDGFD,TNC::PDGFD,etc.,through mole-cular profiling.These atypical rearrangements may be encountered in morpho-logically classic DFSP,unusual anatomic sites,or diagnostically challenging variants such as fibrosarcomatous DFSP.Their recognition is clinically relevant,as they may influence tumor biology,response to targeted therapy,and eligibility for clinical trials.This newly documented DFSP involving the lacrimal sac was initially misdiagnosed as a solitary fibrous tumor,emphasizing the diagnostic pitfalls in anatomically constrained regions and the importance of integrated diagnosis combining histology,immunohistochemistry,and molecular testing.In this editorial commentary,we briefly highlight the ever-growing genomic land-scape of DFSP,report rare fusions and their biological implications,and examine the role of expanded molecular diagnostics in refining diagnosis,guiding therapy,and informing prognosis.Incorporating comprehensive fusion analysis into routine workup may be critical for accurate classification,especially in unusual presentations where reliance on morphology alone risks misdiagnosis.展开更多
目的对一个常染色体显性遗传的Van der Hoeve综合征家系进行详尽的临床表型分析及基因突变检测,明确该家系的致病基因突变位点及该突变对基因编码的影响。方法对收集到的Van der Hoeve综合征家系进行包括病史、体格检查及辅助检查在内...目的对一个常染色体显性遗传的Van der Hoeve综合征家系进行详尽的临床表型分析及基因突变检测,明确该家系的致病基因突变位点及该突变对基因编码的影响。方法对收集到的Van der Hoeve综合征家系进行包括病史、体格检查及辅助检查在内的临床资料的收集及外周血液样本的采集,并对22位家系成员进行外显子组测序以及Sanger测序,利用生物信息学软件分析数据。结果该家系共五代,各代连续发病,且每一代男女均可患病,符合常染色体显性遗传特点。该家系中12例患者均自出生时巩膜即呈蓝色且身材矮小,8例患者有骨折病史,可正常愈合,3例患者考虑有Van der Hoeve综合征所致的听力下降,12例患者的COL1A1基因第17号外显子有一个碱基的缺失(c.1128delT),使第376位后的氨基酸编码改变,在第539位提前结束氨基酸编码,该家系中10例无症状者无此突变。结论该家系患者确定为由COL1A1基因c.1128delT突变导致的Van der Hoeve综合征。展开更多
【目的】探明COL1A1(Collagen type I alpha 1 chain,I型胶原蛋白α1链)和COL1A2(Collagen type I alpha 2 chain,I型胶原蛋白α2链)基因在梅花鹿不同组织中的表达谱,解析其对梅花鹿组织发育的影响,为影响梅花鹿重要经济性状的候选基因...【目的】探明COL1A1(Collagen type I alpha 1 chain,I型胶原蛋白α1链)和COL1A2(Collagen type I alpha 2 chain,I型胶原蛋白α2链)基因在梅花鹿不同组织中的表达谱,解析其对梅花鹿组织发育的影响,为影响梅花鹿重要经济性状的候选基因筛选提供依据。【方法】采用RT-qPCR方法检测COL1A1和COL1A2基因在雄性梅花鹿心脏、肝脏和脾脏等16个组织器官中的表达水平;结合NetPhos 3.1、Motif Search和ProtParam等系列软件预测分析COL1A1和COL1A2基因的生物信息及其在梅花鹿不同组织中的表达谱,并在此基础上构建COL1A1和COL1A2氨基酸序列的系统发育进化树。【结果】COL1A1和COL1A2基因CDS区分别编码1463和1364个氨基酸,理论PI分别为5.60和9.19,COL1A1和COL1A2均是一种具有信号肽和磷酸化位点的亲水性稳定蛋白质;二者蛋白二级及三级结构均以无规则卷曲构成;与其他动物相比,鹿COL1A1和COL1A2基因均与反刍动物山羊、绵羊和牛的同源性最高,其中,鹿COL1A1基因与山羊、牛、绵羊的同源性分别为99.5%、99.5%和99.2%,鹿COL1A2基因与牛、绵羊、山羊的同源性分别为99.1%、99.0%和98.9%,亲缘关系最近。RT-qPCR结果显示,COL1A1和COL1A2基因在梅花鹿不同组织中均有表达,其中COL1A1基因在心脏、背最长肌和腿肌中的表达较高,显著高于其他组织,COL1A2基因在心脏、肝脏、肾脏和瓣胃中的表达较高,均显著高于其他组织;此外,COL1A1在肌肉组织中的表达较高,COL1A2较低;二者在其余组织中的表达具有一高一低,相互协同的作用趋势。【结论】COL1A1和COL1A2可能通过相互协同共同维持组织结构及组织发育,相关结果为后续深入研究COL1A1和COL1A2影响梅花鹿生长发育奠定基础。展开更多
目的:探讨COL1A1和miR-143在结直肠癌中的表达水平和临床意义以及两者的相关性。方法:收集80例结直肠癌患者的组织蜡块和50例结直肠癌患者的新鲜标本,分别用IHC和qRT-PCR检测COL1A1和miR-143的表达水平,并利用统计学方法分析两者表达水...目的:探讨COL1A1和miR-143在结直肠癌中的表达水平和临床意义以及两者的相关性。方法:收集80例结直肠癌患者的组织蜡块和50例结直肠癌患者的新鲜标本,分别用IHC和qRT-PCR检测COL1A1和miR-143的表达水平,并利用统计学方法分析两者表达水平的相关性及与患者临床病理参数的关系。结果:在结直肠癌组织中,COL1A1的表达高于癌旁组织(P Objective: To investigate the expression level and clinical significance of COL1A1 and miR-143 in colorectal cancer and their correlation. Methods: Collect tissue wax blocks from 80 patients with colorectal cancer and fresh specimens from 50 patients with colorectal cancer. The expression levels of COL1A1 and miR-143 were detected by IHC and qRT-PCR, respectively, and the correlation between the expression levels of the two genes and their relationship with clinical pathological parameters were analyzed using statistical methods. Results: In colorectal cancer tissues, the expression of COL1A1 was higher than that of adjacent tissues (P < 0.001), and the expression of miR-143 was lower than that of adjacent tissues (P < 0.001). The relative expression levels of the two were significantly negatively correlated. All are related to tumor diameter, degree of differentiation, lymph node metastasis, TNM staging (P value < 0.05);Conclusion: 1) In colorectal cancer tissues, the expression of COL1A1 increases, the expression of miR-143 decreases, and when the expression of miR-143 is low, COL1A1mRNA expression is high, and vice versa;2) Both expression levels are related to tumor diameter, degree of differentiation, lymph node metastasis and TNM stage.展开更多
目的:探讨隆突性皮肤纤维肉瘤(dermatofibrosarcoma protuberans,DFSP)诊断中免疫表型和荧光原位杂交(fluorescence in situ hybridization,FISH)检测COL1A1/PDGFB融合基因的应用价值。方法:观察73例DFSP中免疫组织化学标记物vimentin、...目的:探讨隆突性皮肤纤维肉瘤(dermatofibrosarcoma protuberans,DFSP)诊断中免疫表型和荧光原位杂交(fluorescence in situ hybridization,FISH)检测COL1A1/PDGFB融合基因的应用价值。方法:观察73例DFSP中免疫组织化学标记物vimentin、CD34、CD99、S100、desmin、SMA和FISH检测COL1A1/PDGFB融合基因的表达。选取85例非DFSP作为免疫组织化学的对照组,10例非DFSP作为FISH检测COL1A1/PDGFB融合基因的对照组。结果:vimentin、CD34、CD99、S100、desmin、SMA在73例DFSP中阳性率分别是100%、91.78%、61.64%、0、0、6.85%,在对照组中不同程度表达,其中CD34的表达在鉴别诊断中有意义。COL1A1/PDGFB融合基因在DFSP的阳性率为86.96%(60/69),对照组均阴性。结论:在DFSP的诊断中,COL1A1/PDGFB融合基因是DFSP较为特异性、敏感性的标记,而CD34是DFSP相对理想的标记。展开更多
目的对一个常染色体显性遗传的Van der Hoeve综合征家系进行详尽的临床表型分析及可能的致病基因COL1A1突变检测,探讨该家系基因型及表型的关系。方法对收集到的Van der Hoeve综合征家系进行病史及血液样本采集,并对家庭主要成员进行COL...目的对一个常染色体显性遗传的Van der Hoeve综合征家系进行详尽的临床表型分析及可能的致病基因COL1A1突变检测,探讨该家系基因型及表型的关系。方法对收集到的Van der Hoeve综合征家系进行病史及血液样本采集,并对家庭主要成员进行COL1A1基因全部外显子DNA序列分析,利用Gene Tool软件及分子生物学网站的信息分析检测数据。结果该家系先证者及其母亲COL1A1基因第40号外显子有两个碱基的缺失(c.2910_2911delAG),导致COL1A1编码的蛋白质的翻译合成在第980位氨基酸提前终止。先证者父亲无此突变。结论该家系先证者及其母亲确定为由c.2910_2911delAG突变导致的Van der Hoeve综合征。与COL1A1基因突变数据库比对,该突变位点未曾报道过。展开更多
文摘Dermatofibrosarcoma protuberans(DFSP)is a rare cutaneous intermediate-grade soft tissue tumor characterized by COL1A1::PDGFB fusion in most cases.This fusion drives tumorigenesis and forms the basis for imatinib treatment,which acts by blocking platelet-derived growth factor receptor-beta kinase activity.Apart from this canonical fusion,there is an expanding spectrum of rare fusions,including COL6A3::PDGFD,EMILIN::PDGFD,TNC::PDGFD,etc.,through mole-cular profiling.These atypical rearrangements may be encountered in morpho-logically classic DFSP,unusual anatomic sites,or diagnostically challenging variants such as fibrosarcomatous DFSP.Their recognition is clinically relevant,as they may influence tumor biology,response to targeted therapy,and eligibility for clinical trials.This newly documented DFSP involving the lacrimal sac was initially misdiagnosed as a solitary fibrous tumor,emphasizing the diagnostic pitfalls in anatomically constrained regions and the importance of integrated diagnosis combining histology,immunohistochemistry,and molecular testing.In this editorial commentary,we briefly highlight the ever-growing genomic land-scape of DFSP,report rare fusions and their biological implications,and examine the role of expanded molecular diagnostics in refining diagnosis,guiding therapy,and informing prognosis.Incorporating comprehensive fusion analysis into routine workup may be critical for accurate classification,especially in unusual presentations where reliance on morphology alone risks misdiagnosis.
文摘目的对一个常染色体显性遗传的Van der Hoeve综合征家系进行详尽的临床表型分析及基因突变检测,明确该家系的致病基因突变位点及该突变对基因编码的影响。方法对收集到的Van der Hoeve综合征家系进行包括病史、体格检查及辅助检查在内的临床资料的收集及外周血液样本的采集,并对22位家系成员进行外显子组测序以及Sanger测序,利用生物信息学软件分析数据。结果该家系共五代,各代连续发病,且每一代男女均可患病,符合常染色体显性遗传特点。该家系中12例患者均自出生时巩膜即呈蓝色且身材矮小,8例患者有骨折病史,可正常愈合,3例患者考虑有Van der Hoeve综合征所致的听力下降,12例患者的COL1A1基因第17号外显子有一个碱基的缺失(c.1128delT),使第376位后的氨基酸编码改变,在第539位提前结束氨基酸编码,该家系中10例无症状者无此突变。结论该家系患者确定为由COL1A1基因c.1128delT突变导致的Van der Hoeve综合征。
文摘【目的】探明COL1A1(Collagen type I alpha 1 chain,I型胶原蛋白α1链)和COL1A2(Collagen type I alpha 2 chain,I型胶原蛋白α2链)基因在梅花鹿不同组织中的表达谱,解析其对梅花鹿组织发育的影响,为影响梅花鹿重要经济性状的候选基因筛选提供依据。【方法】采用RT-qPCR方法检测COL1A1和COL1A2基因在雄性梅花鹿心脏、肝脏和脾脏等16个组织器官中的表达水平;结合NetPhos 3.1、Motif Search和ProtParam等系列软件预测分析COL1A1和COL1A2基因的生物信息及其在梅花鹿不同组织中的表达谱,并在此基础上构建COL1A1和COL1A2氨基酸序列的系统发育进化树。【结果】COL1A1和COL1A2基因CDS区分别编码1463和1364个氨基酸,理论PI分别为5.60和9.19,COL1A1和COL1A2均是一种具有信号肽和磷酸化位点的亲水性稳定蛋白质;二者蛋白二级及三级结构均以无规则卷曲构成;与其他动物相比,鹿COL1A1和COL1A2基因均与反刍动物山羊、绵羊和牛的同源性最高,其中,鹿COL1A1基因与山羊、牛、绵羊的同源性分别为99.5%、99.5%和99.2%,鹿COL1A2基因与牛、绵羊、山羊的同源性分别为99.1%、99.0%和98.9%,亲缘关系最近。RT-qPCR结果显示,COL1A1和COL1A2基因在梅花鹿不同组织中均有表达,其中COL1A1基因在心脏、背最长肌和腿肌中的表达较高,显著高于其他组织,COL1A2基因在心脏、肝脏、肾脏和瓣胃中的表达较高,均显著高于其他组织;此外,COL1A1在肌肉组织中的表达较高,COL1A2较低;二者在其余组织中的表达具有一高一低,相互协同的作用趋势。【结论】COL1A1和COL1A2可能通过相互协同共同维持组织结构及组织发育,相关结果为后续深入研究COL1A1和COL1A2影响梅花鹿生长发育奠定基础。
文摘目的:探讨COL1A1和miR-143在结直肠癌中的表达水平和临床意义以及两者的相关性。方法:收集80例结直肠癌患者的组织蜡块和50例结直肠癌患者的新鲜标本,分别用IHC和qRT-PCR检测COL1A1和miR-143的表达水平,并利用统计学方法分析两者表达水平的相关性及与患者临床病理参数的关系。结果:在结直肠癌组织中,COL1A1的表达高于癌旁组织(P Objective: To investigate the expression level and clinical significance of COL1A1 and miR-143 in colorectal cancer and their correlation. Methods: Collect tissue wax blocks from 80 patients with colorectal cancer and fresh specimens from 50 patients with colorectal cancer. The expression levels of COL1A1 and miR-143 were detected by IHC and qRT-PCR, respectively, and the correlation between the expression levels of the two genes and their relationship with clinical pathological parameters were analyzed using statistical methods. Results: In colorectal cancer tissues, the expression of COL1A1 was higher than that of adjacent tissues (P < 0.001), and the expression of miR-143 was lower than that of adjacent tissues (P < 0.001). The relative expression levels of the two were significantly negatively correlated. All are related to tumor diameter, degree of differentiation, lymph node metastasis, TNM staging (P value < 0.05);Conclusion: 1) In colorectal cancer tissues, the expression of COL1A1 increases, the expression of miR-143 decreases, and when the expression of miR-143 is low, COL1A1mRNA expression is high, and vice versa;2) Both expression levels are related to tumor diameter, degree of differentiation, lymph node metastasis and TNM stage.
文摘目的:探讨隆突性皮肤纤维肉瘤(dermatofibrosarcoma protuberans,DFSP)诊断中免疫表型和荧光原位杂交(fluorescence in situ hybridization,FISH)检测COL1A1/PDGFB融合基因的应用价值。方法:观察73例DFSP中免疫组织化学标记物vimentin、CD34、CD99、S100、desmin、SMA和FISH检测COL1A1/PDGFB融合基因的表达。选取85例非DFSP作为免疫组织化学的对照组,10例非DFSP作为FISH检测COL1A1/PDGFB融合基因的对照组。结果:vimentin、CD34、CD99、S100、desmin、SMA在73例DFSP中阳性率分别是100%、91.78%、61.64%、0、0、6.85%,在对照组中不同程度表达,其中CD34的表达在鉴别诊断中有意义。COL1A1/PDGFB融合基因在DFSP的阳性率为86.96%(60/69),对照组均阴性。结论:在DFSP的诊断中,COL1A1/PDGFB融合基因是DFSP较为特异性、敏感性的标记,而CD34是DFSP相对理想的标记。
文摘目的对一个常染色体显性遗传的Van der Hoeve综合征家系进行详尽的临床表型分析及可能的致病基因COL1A1突变检测,探讨该家系基因型及表型的关系。方法对收集到的Van der Hoeve综合征家系进行病史及血液样本采集,并对家庭主要成员进行COL1A1基因全部外显子DNA序列分析,利用Gene Tool软件及分子生物学网站的信息分析检测数据。结果该家系先证者及其母亲COL1A1基因第40号外显子有两个碱基的缺失(c.2910_2911delAG),导致COL1A1编码的蛋白质的翻译合成在第980位氨基酸提前终止。先证者父亲无此突变。结论该家系先证者及其母亲确定为由c.2910_2911delAG突变导致的Van der Hoeve综合征。与COL1A1基因突变数据库比对,该突变位点未曾报道过。